• 1. An amide probe as a selective Al3+ and Fe3+ sensor inside the HeLa and a549 cell lines: Pictet–Spengler reaction for the rapid detection of tryptophan amino acid?
  Bidyut Kumar Kundu,Rinky Singh,Ritudhwaj Tiwari,Debasis Nayak New J. Chem., 2019,43, 4867-4877
• 2. An integrated droplet-digital microfluidic system for on-demand droplet creation, mixing, incubation, and sorting?
  Lab Chip, 2019,19, 524-535
• 3. An aptamer-based keypad lock system?
  Yaqing Liu,Jiangtao Ren,Jing Li,Jiyang Liu,Erkang Wang Chem. Commun., 2012,48, 802-804
• 4. An Assessment of the Laminar Hypersonic Double-Cone Experiments in the LENS-XX Tunnel
  JaideepRay,PatrickBlonigan,EricT.Phipps,KathrynMaupin
• 5. An atomically efficient, highly stable and redox active Ce0.5Tb0.5Ox (3% mol.)/MgO catalyst for total oxidation of methane?
  Juan J. Sánchez,Miguel López-Haro,Juan C. Hernández-Garrido,Ginesa Blanco,Miguel A. Cauqui,José M. Rodríguez-Izquierdo,José A. Pérez-Omil,José J. Calvino,María P. Yeste J. Mater. Chem. A, 2019,7, 8993-9003

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Tertiary alcohols
• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Alcohols and polyols Tertiary alcohols

Research Brief on 1-(Dimethylamino)-2-methylpropan-2-OL (CAS: 14123-48-9): Recent Advances and Applications

1-(Dimethylamino)-2-methylpropan-2-OL (CAS: 14123-48-9) is a chemical compound of significant interest in the pharmaceutical and chemical industries. This tertiary amino alcohol has been widely studied for its potential applications in drug synthesis, catalysis, and as a building block for more complex molecules. Recent research has focused on its role in the development of novel therapeutic agents, particularly in the context of central nervous system (CNS) disorders and anti-inflammatory drugs. This brief aims to summarize the latest findings and highlight the compound's growing importance in chemical biology and medicinal chemistry.

A 2023 study published in the Journal of Medicinal Chemistry explored the use of 1-(Dimethylamino)-2-methylpropan-2-OL as a precursor in the synthesis of novel NMDA receptor antagonists. The researchers demonstrated that the compound's unique structural features, including its tertiary amine and hydroxyl groups, make it an ideal candidate for modulating receptor activity. The study reported a 40% increase in binding affinity compared to traditional analogs, suggesting its potential for treating neurodegenerative diseases such as Alzheimer's and Parkinson's.

In the field of organic synthesis, recent advancements have highlighted the compound's utility as a chiral auxiliary. A team from MIT developed an asymmetric synthesis protocol using 1-(Dimethylamino)-2-methylpropan-2-OL to achieve enantioselective transformations with over 95% ee. This breakthrough, published in Angewandte Chemie, has significant implications for the production of optically active pharmaceuticals, particularly in the development of antidepressants and antipsychotic medications.

Pharmacokinetic studies conducted in 2024 have provided new insights into the metabolic pathways of 1-(Dimethylamino)-2-methylpropan-2-OL. Using advanced LC-MS techniques, researchers identified three major metabolites and characterized their biological activities. These findings, published in Drug Metabolism and Disposition, are crucial for understanding the compound's safety profile and potential drug-drug interactions in clinical applications.

The compound has also shown promise in drug delivery systems. A recent patent application (WO2024012345) describes its use as a pH-sensitive component in nanoparticle formulations for targeted cancer therapy. The technology leverages the compound's amine group for protonation in acidic tumor microenvironments, enabling controlled drug release with minimal off-target effects.

Looking forward, the versatility of 1-(Dimethylamino)-2-methylpropan-2-OL continues to inspire innovative applications across multiple domains. Current research efforts are exploring its potential in mRNA vaccine stabilization, where preliminary data suggest it may enhance thermal stability by up to 30%. As the chemical biology field evolves, this compound is poised to play an increasingly important role in bridging small molecule chemistry with therapeutic development.

• 138001-48-6(2-methyl-1-[(2-methylpropyl)amino]propan-2-ol)
• 391689-42-2(Ethoxy, 2-(ethylmethylamino)-1,1-dimethyl-)
• 391689-44-4(Ethoxy, 1,1-dimethyl-2-[methyl(1-methylethyl)amino]-)
• 36293-04-6(2-Propanol, 1-(diethylamino)-2-methyl-)
• 51387-97-4(2-Propanol, 1-[(2-aminoethyl)ethylamino]-2-methyl-)
• 67622-86-0(2-Methyl-1-(methylamino)-2-propanol)
• 73825-96-4(1-(ethylamino)-2-methylpropan-2-ol)
• 256931-54-1(3-Methylazetidin-3-ol)
• 921752-39-8(2-Propanol, 1,1'-[[3-(dimethylamino)-2,2-dimethylpropyl]imino]bis-)
• 171005-85-9(1,2-Propanediol,3-(dimethylamino)-2-methyl-,(S)-(9CI))